title: Selection of clinically meaningful primary endpoints in phase 3 clinical trials in idiopathic pulmonary fibrosis.
authors.forename: Williamson Z
authors.initials: WZ
authors.lastname: Bradford
authors.forename: Alan H
authors.initials: AH
authors.lastname: Cohen
authors.forename: Jonathan A
authors.initials: JA
authors.lastname: Leff
mesh_terms: D017326:Clinical Trials, Phase III as Topic / Q000379:methods*; D023381:Endpoint Determination / Q000379:methods*; D006801:Humans; D054990:Idiopathic Pulmonary Fibrosis / Q000188:drug therapy*; D019141:Respiratory System Agents / Q000627:therapeutic use*
chemical_list: D019141:Respiratory System Agents